Douglas Braun, PharmD, CSP, RPh, CPh, is the vice president of AON Pharmacy with over 35 years of experience, including working alongside the executive team of the American Oncology Network since its inception. Braun specializes in the leadership and growth of specialty pharmacy operations and is responsible for ensuring that AON’s clinics and patients receive the highest level of service and care.

Born in Brooklyn, New York, and a resident of Naples, Florida, Braun is a driving force in the workplace, using his positive attitude and tireless energy to inspire others. Outside of work, he volunteers at local hospice and drug treatment centers. Braun is inspired daily by his wife and their two daughters.

As vice president of human resources, Karen brings more than 20 years of expertise in HR operations within healthcare organizations. She oversees HR strategy, including employee engagement and leadership development, and serves as a strategic partner, collaborator, and mentor. She is passionate about finding solutions that enhance the organization’s culture and is responsible for developing HR initiatives to integrate new practices into AON.

Karen’s previous roles include HR director for Florida Cancer Specialists and Research Institute and HR manager for Laboratory Corporation of America. She is committed to creating a workplace where employees feel valued and empowered.

Originally from Pennsylvania, Karen earned a degree in psychology from Mansfield University and holds the SPHR designation. She enjoys hiking, biking, and taking advantage of Florida’s warm weather.

Dr. Indurlal leads AON’s practice operations, overseeing clinics in the Central and West regions and providing operational assistance to clinics transitioning to value-based care models.

He has more than a decade of experience in oncology, healthcare management, and value-based care, leading initiatives that bridge clinical excellence with cost-effective outcomes. Most recently, he served as the senior director of care transformation and analytics at The US Oncology Network, where he led the adoption and implementation of value-based care programs across the network. Prior to that, he was the director of clinical services and operations for Illinois Cancer Specialists, a large medical/radiation oncology practice in the Chicago region, and he previously held an operational leadership role at Fox Valley Hematology Oncology in Illinois. He is experienced in medical management, healthcare strategy, operational execution, financial management, utilization management, care redesign and transformation, practice growth, healthcare quality, alternative payment models, payer relationships, and data and analytics.

Originally trained and licensed as a physician in India, Dr. Indurlal holds an MD, a master’s degree in healthcare informatics, and Six Sigma certification. His research on oncology value-based care and care transformation has been presented at national conferences such as ASCO and NCCN. He has published articles in JCO, JAPhA and JNCCN, and has presented at national and industry conferences on value-based care, provider strategy, practice management, and care transformation.

David serves as the Chief Financial & Operating Officer (CFO and COO) and brings over 25 years of private equity-backed and public company experience in high growth environments to AON’s executive team. His extensive financial, revenue cycle and operating experience spans companies across various healthcare services sectors, including pediatric and adult home health, long-term acute care and multi-specialty physician practices. David’s background includes significant M&A, integrations, capital markets and initial public offering experience across the companies he has served.

Prior to joining AON, he served as CFO for U.S. Heart and Vascular, Aveanna Healthcare, and ApolloMD. He also held leadership positions at the Public Company Accounting Oversight Board, Regency Hospital Company and EY.

David graduated magna cum laude with a Bachelor of Science in Accounting from the University of Maryland. He then passed the CPA exam, scoring among the top 10 in Maryland and a high score nationally. His achievements were acknowledged in 2023 when he was ranked No. 9 in the “Top 25 CFOs of Georgia” by Finance & Investing magazine.

Bill has served on various boards including Fresenius Medical Care AG Management Board, Fresenius Medical Care Holdings, Inc., Sound Physicians, Interwell Health and Vifor FMC Renal Pharma, Ltd. From 2017 to 2023, he served as chief executive officer of FMC North America and then chief executive officer of global care delivery at Fresenius Medical Care AG. Before that, Bill spent seven years at Fresenius Medical Care Holdings, Inc., having served as president of Fresenius Kidney Care and having held leadership positions in Azura Vascular Care, business development, real estate/construction services, renal integrated strategies, Fresenius Rx and Spectra Laboratories. His other career experience includes a seven-year tenure at Innovative Health Strategies, LLC.; twelve years at Gambro Healthcare, Inc.; and positions at Gambro Healthcare, Inc.; CD Medical, Inc.; and Analytab Products, Inc.

As vice president of mergers and acquisitions (M&A), Kyle is responsible for identifying and developing new partnerships with physicians and health systems. He brings over 12 years of experience in corporate finance, strategy and consulting related to physician practices.

Before joining AON, Kyle held leadership roles at Sound Physicians, a national inpatient physician practice management organization. At the end of a six-year tenure focused on M&A and growth initiatives at Sound Physicians, he played a key role in developing and managing the organization’s first accountable care organization, which partners with physicians to improve quality and outcomes for Medicare beneficiaries.

Kyle began his career in healthcare investment banking and healthcare consulting with various firms in Nashville, Tennessee. He holds a Bachelor of Business Administration degree from East Tennessee State University in corporate finance and accounting and is a graduate of the Institute of Business and Government Affairs at Georgetown University.

Mark is responsible for overseeing AON’s information technology (IT) and serves as a member of the MiBA (Meaningful Insights Biotech Analytics) leadership team, which is a cutting-edge data source for cancer research, clinical trial matching, pharma utilization and new drug development.

He specializes in envisioning and managing technology-based solutions that support the ongoing improvement and continuity of high-quality patient care as well as bringing top-of-line innovative technology knowledge to help with the advancements in precision oncology. Mark played a pivotal role at AON by building the IT infrastructure that positioned the company for fast growth and its transition to going public in September 2023. He is a recipient of the CIO of the Year award in the corporate sector of the 2023 CIO of the Year ORBIE Awards, which is hosted by SouthFloridaCIO.

Prior to joining AON, Mark served as chief information officer for Florida Cancer Specialists & Research Institute. He also served as vice president of information technology at Promise Healthcare, Inc., the nation’s fifth-largest long-term acute care (LTAC) hospital company, where he was responsible for the leadership and planning of information technology for all the Promise Healthcare locations.

A native of Poland, Mark began his career as a teacher of literature and holds a Master of Arts degree in Polish Philosophy from the University of Wroclaw in Poland. After moving to the United States, he entered the IT field and transitioned to healthcare IT where he quickly embraced the impact technology would have on healthcare operations and patient care.

With more than 30 years of healthcare experience Todd serves AON as Chief Executive Officer and is a Board Member on the Board of Directors. Todd is responsible for overseeing AON’s mission, strategy, operations and finances. As President & Chief Operating Officer of AON since its inception in 2017 to 2021, he made significant contributions across practice operations, central ancillaries, information technology and strategy.

In his role as Florida Cancer Specialists (FCS) Chief Operating Officer, he was responsible for the day-to-day operations within the corporate office and nearly 100 locations throughout Florida. Prior to his role as COO of FCS in 2011, Todd was Senior Vice President and Chief Information Officer for US Oncology. As part of the senior management team, Todd helped set organizational goals and objectives, oversaw strategic project prioritization, and led tactical execution of company-wide initiatives. He was also responsible for all day-to-day operational aspects of information technology and strategic direction for the information technology needs of the organization. While Senior Vice President and Chief Information Officer, he was named to the Information Week 500 and received the ComputerWorld/IDG Laureate Award, recognizing individuals and organizations that use information technology to benefit society. During his tenure at US Oncology, he also held positions as the Director of Enterprise Applications and Vice President of Information Systems. Todd’s consulting and management experience in healthcare information technology includes positions with Datamedic Corporation (acquired by VitalWorks and later Amicas Corporation), Multum Corporation (acquired by Cerner Corporation), and MedE America (acquired by WebMD and later HLTH Corporation).

Todd received a bachelor’s degree in health policy and administration from Pennsylvania State University. Todd has presented at national industry conferences including multiple Community Oncology Alliance (COA) conferences as well as national and regional information technology conferences. Additionally, Ernst & Young LLP named Todd an Entrepreneur Of The Year® 2023 Florida Award finalist. Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures.

As Chief Medical Officer, Dr. Divers will play a vital role in furthering AON’s mission, providing leadership, strategy and vision around practice transformation ensuring that its clinical model addresses patient needs.

Dr. Divers is a Medical Oncologist with Genesis Cancer and Blood Institute, one of the first practices to join the AON network in the summer of 2018. In July of 2020, he was named Advisory Board Chairman.

Dr. Divers has provided physician leadership as a member of several national committees and currently serves on the Board of Directors for the Community Oncology Alliance (COA). He attended medical school at the Louisiana State University School of Medicine. He completed his residency at the University of North Carolina and a fellowship at the University of Alabama at Birmingham Cancer Center.

In addition to his role as CMO, Dr. Divers serves as AON Advisory Board Chairman, Vice Chairman of the Board of Directors and see patients at Genesis Cancer and Blood Institute.

With more than 30 years of healthcare experience Todd serves AON as Chief Executive Officer and is a Board Member on the Board of Directors. Todd is responsible for overseeing AON’s mission, strategy, operations and finances. As President & Chief Operating Officer of AON since its inception in 2017 to 2021, he made significant contributions across practice operations, central ancillaries, information technology and strategy.

In his role as Florida Cancer Specialists (FCS) Chief Operating Officer, he was responsible for the day-to-day operations within the corporate office and nearly 100 locations throughout Florida. Prior to his role as COO of FCS in 2011, Todd was Senior Vice President and Chief Information Officer for US Oncology. As part of the senior management team, Todd helped set organizational goals and objectives, oversaw strategic project prioritization, and led tactical execution of company-wide initiatives. He was also responsible for all day-to-day operational aspects of information technology and strategic direction for the information technology needs of the organization. While Senior Vice President and Chief Information Officer, he was named to the Information Week 500 and received the ComputerWorld/IDG Laureate Award, recognizing individuals and organizations that use information technology to benefit society. During his tenure at US Oncology, he also held positions as the Director of Enterprise Applications and Vice President of Information Systems. Todd’s consulting and management experience in healthcare information technology includes positions with Datamedic Corporation (acquired by VitalWorks and later Amicas Corporation), Multum Corporation (acquired by Cerner Corporation), and MedE America (acquired by WebMD and later HLTH Corporation).

Todd received a bachelor’s degree in health policy and administration from Pennsylvania State University. Todd has presented at national industry conferences including multiple Community Oncology Alliance (COA) conferences as well as national and regional information technology conferences. Additionally, Ernst & Young LLP named Todd an Entrepreneur Of The Year® 2023 Florida Award finalist. Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures.

Bradley has served on the DTOC Board since DTOC’s IPO. He currently advises a number of technology-enabled healthcare companies. From October 2012 to January 2018, he was the Senior Vice President, Chief Healthcare Commercial Market Development Officer and Chief Strategy and Business Development Officer for the Walgreens Company. Prior to Walgreens, Bradley served as an executive in residence at Health Evolution Partners from April 2011 to September 2012, Executive Vice President and Chief Strategy and External Affairs Officer of Anthem Inc. from October 2007 to December 2010, Senior Vice President of National Accounts and Vice President of Enterprise Strategy at Aetna Inc. from March 2005 to September 2007, and Chief Executive Officer for Reden & Anders (Optum Consulting) from October 2002 to February 2005. Bradley currently serves on the board of directors of MJHS in New York City, Performant Financial Corporation, and Premera Blue Cross, among others. He earned a MPP from Harvard University’s Kennedy School of Government and a BBA from the University of Washington. Bradley also serves as a lecturer at the University of Pennsylvania’s Wharton School of Business.

Ravi is Co-Head and Founding Partner of AEA Growth since 2021. He is also the Founder and Managing Partner of ROCA Partners, a growth equity investment firm focused on tech-enabled services, software and healthcare services companies, which he founded in 2015. Previously, he was a principal in the private equity group at Ares Management from 2009 to 2015. Prior to Ares, Ravi was a private equity investor at Bain Capital and a consultant at Bain & Company. He currently serves on the board of directors of several companies including AS Software, Bespoke Partners, Cenegenics, Commonwealth Pain & Spine and Mark Spain Real Estate and previously served on the board of directors of a number of companies including Floor & Decor, Jacuzzi Brands, Ob Hospitalist Group, Oceans Healthcare, Riviera Partners, The Oncology Institute, True Blue Car Wash and Unified Women’s Healthcare. Ravi received a B.S. in Electrical Engineering and a M.S. in Management Science and Engineering from Stanford University and an M.B.A. from Harvard Business School.

.

Tena oversees practice operations for AON in the eastern United States including the successful establishment of Messino Cancer Centers six medical oncology practices within six months. Throughout her 30 years of experience in oncology, Tena has learned, honed, and mastered her clinical, operational, leadership and teamwork acumen. Her work as an oncology nurse and nurse practitioner in both inpatient and outpatient settings has cultivated a well-rounded perspective on patient care. She has successfully led multiple quality initiatives and practice certifications including Quality Oncology Practice Initiative (QOPI) with ASCO, CMS Promoting Interoperability, and physician performance initiatives for a hospital-based quality program.

Like many leaders, Tena did not embark on her career with the goal of being a “leader,” rather, she set out simply to make a difference. Tena’s core principle has always been “patients first” and this is the root of her leadership success. The true mettle of a leader may not be seen in normal day to day operations but in crisis. Over the years, Tena has faced crises with poise and grace. As Clinical Operations Director, Tena oversaw the rebuilding of a medical oncology practice following a tragic fire, re-establishing operations within three days. She has led multiple successful negotiations for practice transformations resulting in continued practice growth and expansion of services. Her commitment to quality oncology care led to the development of multiple outpatient care programs including Survivorship, Oncology Triage Clinic, and Palliative Care. The outcome of these positive developments ranged from improved quality of life to reduced hospital admissions for patients.

In 2001, Tena graduated from Duke University School of Nursing with an MSN and an adult medicine nurse practitioner certificate with a sub-specialty in oncology and HIV. She has received multiple awards and honors throughout her career, including the Thelma Ingle Award for Excellence in Clinical Expertise and Scholarly Activities from the Beta Epsilon Chapter of Sigma Theta Tau. In 2018, Tena completed the Clinical Leadership Fellowship through CTI Leadership.

Caroline leads marketing and communications strategies for AON corporate and its partner practices to strengthen brand and support the organization’s long-term growth initiatives. With over 17 years of successful marketing management and leadership experience, she is a data-driven and creative marketer, having achieved excellent results driving demand generation and business growth. Since joining AON in July 2019, she has devised and implemented numerous impactful external and internal initiatives and campaigns. She was instrumental in the creation of the organization’s refreshed brand strategy and website, launched in 2020. Prior to joining AON, she managed the strategic direction of the marketing plan for Harmony Healthcare, oversaw the brand, product and content marketing for Spectrum Enterprise, and online marketing for Greenway Health.

Caroline holds a Bachelor of Arts in Japanese Studies from the University of London and earned her Masters in Business Administration from Durham University, England. Caroline is proud of her British and Asian heritage and has lived in many different countries including Thailand, Japan, Hong Kong, Cyprus, the Philippines and England.

Alti serves as the chief strategy and innovation officer and is responsible for establishing and reviewing strategic priorities and monitoring the execution of the plans.

He holds a dual Master of Business and Healthcare Administration degree and is a Certified Six Sigma Black Belt.

Alti is proud of his South Asian heritage and has fond memories of his childhood when he lived in the Middle East in the small country of Kuwait. His career in healthcare started as a mental health case worker, which shaped his career in healthcare administration where he felt there was a tremendous gap between medical interventions and the pursuit of public health goals.

Prior to joining AON, Alti spent 15 years at Oncology Consultants in Houston, Texas, a successful community oncology practice. In this role, he pursued value-based care and continuous operational, cost and quality improvements.

Alti believes that the future of healthcare involves a multidisciplinary and unapologetically collaborative approach, keeping the patient at the center of all decisions.

Susan is the vice president of clinical innovation at AON and oversees the clinical programming function that includes care plan design, care program implementation and monitoring, and clinical integration with payers and providers.

She has over 25 years of experience in healthcare. Previously, she was the executive director of clinical strategy at Oncology Consultants in Houston, Texas, where she developed and implemented innovative clinical strategies and policies that led to the growth of the company. Susan has created clinical and operations protocols for all levels of practice to promote value-based care initiatives in both commercial and non-commercial payer populations. She has established an appropriate framework and oversight, including input into growth, strategy, resourcing, and decision-making to innovate around consumer-focused oncology programs. Developing a community-based oncology navigation program and collaborating to implement a fully integrated initiative to address social determinants of health within the practice has been significant in her role.

Susan currently sits on the COA Administrators Network Board (CAN), the COA Patient Advocacy Network (CPAN) Advisory Panel and the Houston Cancer Health Equity Collaborative. She is an advisor to the Health Equity & Access Committee for the Texas Society of Clinical Oncology (TxSCO) and sits on the COA Health Equity Committee.

Susan holds a Bachelor of Science in Nursing from the University of Pittsburgh and a Master of Science in Nursing Administration from the University of Texas at Arlington. Additionally, she has the Nurse Executive Advanced Certification and has held the Oncology Nurse Certification for 16 years.

James is a partner of AEA Growth and a member of the AEA Growth Investment Committee. Prior to AEA Growth, James was a co-founder and partner of ROCA Partners, a growth equity investment firm focused on tech-enabled services and healthcare services companies. Previously, he served as an M&A executive at IAC/InterActiveCorp, a private equity investor at Ares Management and an investment banker at Lehman Brothers. James has a bachelor’s degree in economics and international relations from the University of Pennsylvania.

Dr. Olson serves as medical director of AON’s pathology laboratory. Prior to joining AON, he worked at Florida Cancer Specialists & Research Institute as a staff hematopathologist for 12 years and as the laboratory medical director for eight.

Dr. Olson received his medical degree from Albany Medical College (AMC) in Albany, New York, and completed a residency at the University of California San Diego and AMC. His training continued with a fellowship in surgical pathology and hematopathology at AMC. Dr. Olson is Board-certified in anatomic pathology, clinical pathology and hematopathology.

Erica is a healthcare-specialized attorney with nearly a decade of transactional and regulatory experience. She is one of less than 130 attorneys in Florida to be Board certified in Health Law by The Florida Bar. Prior to joining AON, Erica most recently served as in-house counsel at Greenway Health, an electronic health record vendor. During her time at Greenway, she focused on vendor management, strategic relationships, and compliance with healthcare regulations. Erica was instrumental in the negotiation, implementation, and ongoing compliance with Greenway’s Corporate Integrity Agreement. Prior to her tenure at Greenway, Erica worked as an attorney in the healthcare group of Carlton Fields, P.A., and previously served as in-house counsel at The Children’s Hospital of Philadelphia, one of the top children’s hospitals in the nation.

Erica is passionate about volunteerism and is particularly dedicated to her role on the Board of Directors of the Children’s Cancer Center, a Tampa-based non-profit that provides emotional, financial, and educational support to more than 1,000 children with cancer or life-threatening blood disorders and their families.

Erica holds a Bachelor of Science degree in Journalism with dual minors in Business and Political Science from Ohio University and a law degree from Drexel University.

Dr. Stephen “Fred” Divers received his medical degree from Louisiana State University where he was selected as a member of Alpha Omega Alpha. He completed his residency in internal medicine at the University of North Carolina at Chapel Hill. During his tenure there, he was named the Outstanding Resident all three years and received the Chairman’s award for his performance in medicine. He completed a dual fellowship in hematology and oncology at the University of Alabama, where he conducted clinical trials in combined modality therapy for lung cancer and translational research with gene arrays and immune checkpoint therapy. He was honored as the Outstanding Clinical Fellow and Outstanding Research Fellow while in Alabama.

Following completion of his training, he joined Genesis Cancer and Blood Institute in Hot Springs, Arkansas in 2004 as a practicing physician. Locally, he served as Chief of Staff for CHI ST Vincent hospital and Chairman of the Cancer Committee. He was instrumental in founding the CPAN chapter for patient advocacy in in Arkansas. He has continued clinical research in the private setting, publishing data from multiple trials involved with cell free DNA sequencing and therapeutics. He continues to serve as a member of the ION advisory panel and on the Community Oncology Alliance as an active board member and Co-Chair for the annual conference.

He and his partners joined the American Oncology Network in 2018 with a group from Louisiana as the founding practices. He is currently Chief Medical Officer as well as Chairman of the Advisory Board for AON and remains passionate about the success of community oncology.

Anthony serves as AON’s Chief Development Officer, beginning in late 2022. He brings with him more than 20 years of experience in company growth, development and leadership.

Anthony joins AON after serving as LifePoint Health’s Vice President of In-Market Development. In his role, he drove acquisitions, joint ventures and other strategic initiatives to diversify the company’s services for its 65 acute care hospitals in 28 states. Prior to that, he was the Chief Development Officer at CleanSlate Centers, Inc. and was responsible for managing the expansion of the company’s footprint of outpatient addiction clinics, growing the platform from 14 centers in two states to 80 centers in 10 states during a four-year period.

Anthony also has served as the Senior Vice President of Business Development for DSI Renal (now U.S. Renal Care), Vice President of Business Development for U.S. HealthWorks (now Concentra), and Executive Vice President of Liberty Dialysis (now Fresenius Medical Care).

He has a background in investment banking and received his MBA with a concentration in finance from UCLA’s Anderson School of Management. He obtained his bachelor’s degree in economics from The Wharton School at the University of Pennsylvania.

Katie oversees AON’s current and future clinical research initiatives. She is passionate about bringing scientific innovation and clinical trial access to the community setting where most oncology patients will receive their care.

Katie has over 25 years of healthcare experience including oncology nursing, clinical research, and program development. After graduating from Florida State University with her Bachelor of Science in Nursing, Katie worked in Atlanta at Emory Hospital where she cared for critically ill patients in medical and surgical critical care units. For the last 19 years, Katie worked at Florida Cancer Specialists & Research Institute in Sarasota, Fla. While there, she developed processes which supported a network of 37 community-based clinical research sites throughout Florida, enrolling over 500 patients annually to phase 1-3 protocols. During her tenure she was responsible for many initiatives including opening two fully dedicated phase 1 clinical trial units and implementing technology solutions used to successfully match patients to clinical trials using clinical and genomic data.

Guy leads AON’s radiation and radiology services. With more than 25 years’ experience Guy has served in a variety of roles gaining a deep understanding of how today’s healthcare is delivered particularly within the diagnostic imaging space.

Prior to joining AON Guy served as Chief Executive Officer of Trident Medical Imaging, a multi-modality diagnostic imaging organization with a primary focus on PET/CT and oncologic imaging. During his tenure at Trident, Guy also served as Chief Financial Officer and Vice President of Sales. In addition, Guy served on the Technical Assessment Committee for Georgia’s Department of Community Health tasked with developing the state’s Certificate of Need Rules for PET/CT scanners and volunteered his services as Chief Financial Officer for the non-profit Outpatient Imaging Coalition.

Guy has been instrumental in developing imaging centers throughout the U.S and his career includes sales management positions with CTI, Siemens, and CYTOGEN. He has served as Director of Nuclear Medicine with a multi-specialty facility and has been published as principal author of peer-reviewed journal articles. He also served as Adjunct Faculty with George Washington University’s Nuclear Medicine Technology program while simultaneously teaching at the US Navy’s Clinical Nuclear Medicine School as Senior Instructor.

Guy received his MBA from Georgia State University and his Bachelor of Science in Health Care Management from Southern Illinois University.

Melody oversees AON’s pharmacy operations, establishes guidelines and standard operating procedures, develops drug utilization and formulary initiatives ensuring cost-effectiveness and optimized therapeutic outcomes. She gives guidance on IV room design and keeps abreast of industry standards to ensure the pharmacy is in compliance with USP 797/USP 800 and state/federal regulatory requirements.

Melody has over 20 years of clinical and management experience in pharmacy. Prior to her role as Vice President of Pharmacy Operations, she was the Director of Pharmacy Operations for Florida Cancer Specialists & Research Institute (FCS) for seven years. She established the pharmacy operational program, drafted the pharmacy training manual, and instituted the regional trainer program that enabled a standard practice throughout nearly 100 FCS locations. Prior to FCS, Melody worked as a lead pediatric oncology pharmacist at Lee Health in Florida, and as an oncology pharmacist at MD Anderson Cancer Center Orlando (now UF Health Cancer Center).

Melody received her Bachelor of Science in Pharmacy from China Medical University in Taiwan and earned her MBA degree from Tulane University in New Orleans. She is a Board-Certified Oncology Pharmacist and has served as a Pharmacist Liaison to the Florida Society of Clinical Oncology (FLASCO) Board of Directors since 2017. She also sits on the Association of Community Cancer Center (ACCC) Oncology Pharmacy Education Network Advisory Committee.

As Vice President of Finance, Michael oversees the analytical support provided to all levels of management throughout the organization. In addition to heading up the analysis of existing operations, Michael works with prospective AON partner physicians to facilitate the transition from individual and group practice to affiliation with AON. His over 20 years of prior experience includes progressive financial roles with McKesson and Cardinal Health, the Timken Company, the acquisition and management of charter schools throughout the southeastern U.S., and, most recently, Florida Cancer Specialists & Research Institute.

Originally from Ohio, Michael earned his bachelor’s degrees in finance, business and education from Walsh University and his MBA from Ashland University. He is also certified as a Six Sigma Green Belt.

Steve serves as Executive Vice President of Practice Operations for AON. Steve most recently served as executive director for the Zangmeister Cancer Center. Prior to that, he held the position of CEO at the Robert C. Byrd Clinic at the West Virginia School of Osteopathic Medicine in Lewisburg, W. Va., CEO and CFO of University Medical Associates, Inc. in Athens, Ohio, and President and CEO of OhioHealth Doctors Hospital in Nelsonville, Ohio.

Steve attended Ohio University, where he earned his Bachelor of Applied Arts degree in accounting and pre-law.

Karen serves as Chief Revenue Cycle Officer at AON where she has oversight of the AON revenue cycle health, supports the development of end-to-end revenue cycle services, utilization management, payer contracting and government and managed care payer regulation and compliance.

Karen joined AON in June of 2022 and brings a proven background in healthcare revenue cycle for organizations like US Oncology, Cancer Treatment Centers of America and MAP Health Management. She was previously Chief Strategy Officer of Value-Based RCM responsible for implementing significant growth in the revenue cycle management business, including potential acquisitions of other billing companies and growth outside the behavioral health vertical.

Karen is an industry veteran with more than 40 years of experience in the areas of healthcare billing/collection, revenue cycle management, and government and managed care payer regulation and compliance. She has held positions with Virtual Radiology, a network of onsite and teleradiology physicians; SPI Healthcare, one of the largest global revenue cycle management organizations with more than 500 employees located in Chicago and Manila; and US Oncology, as the Vice President of Reimbursement Services for 13 years.

Karen holds a Bachelor of Science in Nursing from Lewis A. Wilson School of Nursing.

Kristin serves as Chief Compliance & Risk Officer at AON.

An attorney with more than 15 years of health law experience, Kristin has provided guidance to hospitals, health systems and large physician groups on complex compliance and regulatory issues.

Kristin joined AON in August of 2020. Prior to joining AON, Kristin served as Executive Director-Regulatory and Compliance Counsel at Mercy in St. Louis, which was named one of the top five large U.S. health systems for four consecutive years (2016 to 2019) by IBM Watson Health. During her tenure at Mercy, she served as the primary legal advisor for all compliance and regulatory issues throughout the system, including implementation of and compliance with the requirements of the first three years of a Corporate Integrity Agreement.

Prior to joining Mercy, she served as in-house legal counsel for BJC HealthCare in St. Louis, primarily representing its medical group of over 800 employed physicians, and represented large physician groups and hospital systems within the healthcare practice groups of Squire Patton Boggs and Porter and Wright, Morris and Arthur in Columbus, Ohio.

Kristin holds dual Bachelor of Arts degrees in Political Science and History from University of Missouri-Columbia and a law degree from Capital University Law School.

James serves as Chief Pharmacy & Clinical Services Officer at AON. James joined AON in July of 2021 bringing close to 30 years of experience in both clinical and community oncology industry leadership roles.

Prior to joining AON, James served as Executive Vice President at Georgia Cancer Specialists in Atlanta, overseeing clinical, pharmacy, research, and imaging operations, as well as financial and strategic planning for 26 outpatient oncology clinics and two retail pharmacies and managing over 500 employees.

After earning his PharmD degree from Mercer University Southern School of Pharmacy, James received advanced clinical training from Georgia Baptist Medical Center in Atlanta. He began his career as a clinical pharmacist then transitioned into oncology program administration, as well as managing large clinical research and data mining programs.

Heavily involved in national oncology and pharmacy organizations, James is a member of the American Society of Clinical Oncology, Georgia Society of Clinical Oncology, National Community Oncology Dispensing Association, Inc.’s (NCODA) Executive Counsel, ION’s SON Advisory Panel and Precision Medicine Advisory Panel, and is a member of the American College of Healthcare Executives. He is a reviewer for Community Oncology and Advances in Therapy, and has co-authored over 65 published articles, abstracts, and book chapters.

Dr. Daniel Spitz graduated from medical school at the Medical University of South Carolina, located in Charleston, S.C. and was awarded a Fellowship in Oncology/Hematology at the Bellevue Medical Center located in New York, N.Y. He is Board certified in medical oncology, hematology and internal medicine. Dr. Spitz served on the Board of Directors for the Palm Beach County Chapter of the American Cancer Society and on the National Medical Advisory Board of the National Ovarian Cancer Coalition of Palm Beach.